Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Recent Advances in Bioproduction of Diols: From Concept to Commercialization.

Created on 30 Jul 2026

Authors

Youmeng Liu, Kunyu Liu, Tatsuhisa Tsuboi, Zhen Chen

Published in

Advances in biochemical engineering/biotechnology. Jul 30, 2026. Epub Jul 30, 2026.

Abstract

Diols represent a crucial class of bulk chemicals with extensive applications across the polymer, cosmetics, fuel, food, and pharmaceutical industries. Developing biological routes to produce diols from renewable feedstocks such as biomass and C1 substrates is of great significance for reducing dependence on fossil resources and mitigating carbon dioxide emissions and has therefore attracted widespread attention in recent years. Although the biomanufacturing of some diols has been successfully commercialized, cost-effective bioproduction of most other diols remains challenging. Primary bottlenecks include the lack of efficient natural biosynthetic pathways and the low productivity of engineered strains. This review comprehensively summarizes recent advances in the microbial synthesis of diols, with a particular focus on the development of novel metabolic pathways and metabolic engineering strategies aimed at achieving efficient biosynthesis of C2 to C6 diols. Furthermore, we discuss the current state and major challenges associated with translating these biosynthetic processes into industrial applications, as well as future development prospects.

PMID:
42527672
Bibliographic data and abstract were imported from PubMed on 30 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement